Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 6:16:1588857.
doi: 10.3389/fphar.2025.1588857. eCollection 2025.

Plant polysaccharides influence tumor development based on epigenetics: a review

Affiliations
Review

Plant polysaccharides influence tumor development based on epigenetics: a review

Cong Li et al. Front Pharmacol. .

Abstract

Plant polysaccharides have emerged as pivotal epigenetic modulators in oncology, offering multi-target therapeutic potential to address toxicity and drug resistance limitations of conventional therapies. This review integrates evidences from multi-database (PubMed, Web of Science and CNKI, 2010-2025) to elucidate three core epigenetic mechanisms of plant polysaccharides (e.g., Astragalus and Ganoderma lucidum): 1) TET2-mediated DNA demethylation; 2) inhibition of histone-modifying enzymes including JMJD2D; 3) regulation of tumor-suppressive miRNAs such as miR-139-5p. Preclinical studies demonstrate synergistic effects with chemotherapeutics, enhancing antitumor efficacy while reducing toxicity through immune modulation (e.g., H22 murine models) and organ protection (e.g., cisplatin regimens). Bibliometric analyses further uncover emerging roles in tumor microenvironment reprogramming, angiogenesis suppression, and macrophage polarization. These findings establish plant polysaccharides as precision oncology agents bridging molecular mechanisms with clinical translation. Future research should prioritize structural standardization, pharmacokinetic profiling, and combinatorial therapy optimization to accelerate clinical translation.

Keywords: apoptosis; epigenetic; oncology agent; plant polysaccharides; tumor development.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Epigenetic mechanisms of tumor formation. (a) The role of non-coding RNAs in tumor development (Dang, 2012; Ritchie et al., 2015; Olivero et al., 2020). (b) The role of histone modifications in tumor development (Berry et al., 2014; Yuan et al., 2015; Hu et al., 2018). (c) The role of DNA methylation in tumor development (Sakuma et al., 2006; Witt et al., 2009). (d) Other epigenetic roles (Li R. J. et al., 2015; Tarcic et al., 2016; Zhao et al., 2020).
FIGURE 2
FIGURE 2
The AFM picture of green tea amylase. (a) 4⋅2 μm × 4⋅2 μm; (b) 1⋅5μm × 1⋅5 μm (Qin et al., 2009).
FIGURE 3
FIGURE 3
The effect of plant polysaccharides on epigenetic effects on tumors.
FIGURE 4
FIGURE 4
Diagram of other applications of plant polysaccharides.

Similar articles

Cited by

References

    1. Abu-Khudir R., Ismail G. A., Diab T. (2020). Antimicrobial, antioxidant, and anti-tumor activities of sargassum linearifolium and cystoseira crinita from egyptian mediterranean coast. Nutr. Cancer (1), 1–16. - PubMed
    1. Ahmad M. M., Chatha S. a.S., Iqbal Y., Hussain A. I., Khan I., Xie F. W. (2022). Recent trends in extraction, purification, and antioxidant activity evaluation of plant leaf-extract polysaccharides. Biofuels Bioprod. and Biorefining-Biofpr 16 (6), 1820–1848. 10.1002/bbb.2405 - DOI
    1. Anastasiadou E., Jacob L. S., Slack F. J. (2018). Non-coding RNA networks in cancer. Nat. Rev. Cancer 18 (1), 5–18. 10.1038/nrc.2017.99 - DOI - PMC - PubMed
    1. Bae H., Lee J. Y., Yang C., Song G., Lim W. (2020). Fucoidan derived from fucus vesiculosus inhibits the development of human ovarian cancer via the disturbance of calcium homeostasis, endoplasmic reticulum stress, and angiogenesis. Mar. Drugs 18 (1), 45. 10.3390/md18010045 - DOI - PMC - PubMed
    1. Bai X. F., Liu J., Li O., Zheng P., Liu Y. (2003). Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes. J. Clin. Invest. 111 (10), 1487–1496. 10.1172/JCI17656 - DOI - PMC - PubMed

LinkOut - more resources